Showing 2781-2790 of 3315 results for "".
- Rayner Announces 1,000 IOLs Recorded on RayPRO Digital Platformhttps://modernod.com/news/rayner-announces-1000-iols-recorded-on-raypro-digital-platform/2479436/Rayner announced that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform. Launched at ASCRS in 2019 for ophthalmic surgeons who perform cataract procedures, RayPRO is a web-based and mobile digital platform th
- Eyevensys Raises $12M in a Series B Plus Funding Roundhttps://modernod.com/news/eyevensys-raises-12m-in-a-series-b-plus-funding-round/2479435/Eyevensys announced it has raised $12 million in a Series B Plus funding round. Korea Investment Partners is leading the Series B Plus financing and existing investors will also join the round. The financing will support Eyevensys’ accelerated development of its EYS809 program for the tr
- IrisVision Names Naeem Kayani President & Chief Operating Officerhttps://modernod.com/news/irisvision-names-naeem-kayani-president-chief-operating-officer/2479431/IrisVision announced the addition of Naeem Kayani to serve as President and Chief Operating Officer. Launched in 2017, IrisVision’s flagship consumer product employs breakthrough, smart software lens technology that leverages functional areas of the eyes to restore vision instantly. Design
- Scientists Discover Gene Therapy Provides Neuroprotection to Prevent Glaucoma Vision Losshttps://modernod.com/news/scientists-discover-gene-therapy-provides-neuroprotection-to-prevent-glaucoma-vision-loss/2479407/A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH’s National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and b
- Monty Montoya Appointed CEO of TherOptixhttps://modernod.com/news/monty-montoya-appointed-ceo-of-theroptix/2479395/Monty Montoya has been named chief executive officer of TherOptix, a preclinical biopharma company focused on delivering clinically impactful therapeutics via a drug-eluting contact lens platform. TherOptix has received orphan drug designation on its lead candidate (001) for prevention of prolife
- ArcScan Signs Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technologyhttps://modernod.com/news/arcscan-signs-agreement-for-11-15-million-preferred-series-b-investment-with-shanghai-haohai-biological-technology/2479394/ArcScaan announced the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology that will result in a $11.15 million Preferred Series B investment into ArcScan. Haohai is a leading Chinese ophthalmology and medical aesthetics company headquartered in Shanghai, and is pub
- Alcon to Share New Data and Live Booth Presentations at ASCRShttps://modernod.com/news/alcon-to-share-new-data-and-live-booth-presentations-at-ascrs/2479391/Alcon will have approximately 70 abstracts highlighting the benefits of the Alcon Cataract and Refractive suite. A few highlights of the Alcon data include: Robust data demonstrates extremely high level of patient satisfaction and increased spectacle independence for market-leading <
- Allergan to Present New Data from its Eye Care Portfolio at the 2021 ASCRShttps://modernod.com/news/allergan-to-present-new-data-from-its-eye-care-portfolio-at-the-2021-ascrs/2479386/Allergan announced that it will present new data from its leading portfolio of eye care medicines at the 2021 ASCRS (American Society for Cataract and Refractive Surgery) annual meeting being held July 23-27 in Las Vegas. Presentations will include new data on AGN-190584 (pilocarpine 1.25%), an i
- Heru Bolsters Executive Team with Seasoned Industry Veteranshttps://modernod.com/news/heru-bolsters-executive-team-with-seasoned-industry-veterans/2479373/Heru, a developer of wearable AI-powered vision diagnostics and augmentation software, has expanded its executive leadership team with the appointment of several strategic hires. Joining Heru are Mary Durbin, PhD, as Chief Scientific Officer; Bob George as Chief Technology Officer; Corey Nielson
- Hoya Vision Care and Myopia Profile Training the Visionaries of the Futurehttps://modernod.com/news/hoya-vision-care-and-myopia-profile-training-the-visionaries-of-the-future/2479370/Hoya Vision Care announced the roll out of a suite of co-created certified training courses to educate, inform and empower eye care professionals (ECPs) to prescribe spectacle lenses for children in the global fight t